Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00537303 · ClinicalTrials.gov registry record · Phase 4
Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes
A Phase 4 study, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- Phase 4
- Development phase
- 296
- Enrollment target
NCT00537303: Completed Phase 4 study, sponsored by Novo Nordisk A/S.
NCT00537303 is a Phase 4 study that has completed, run by Novo Nordisk A/S. The registered enrollment target is 296 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00537303, a Phase 4 study, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 296 participants
- Enrollment target
Study Summary
This trial is conducted in Europe, Africa and the United States of America (USA). The aim of this trial is to compare the safety and efficacy of two different insulin treatments, the "basic" and the "advanced" treatment in type 2 diabetes.
Primary Outcome
Analysed for the full analysis set.
Interventions
- DRUG insulin aspart
- DRUG insulin detemir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 296 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-03 |
| Phase | Phase 4 |
What the finished NCT00537303 record still lists
NCT00537303 is an interventional study that assigns participants to a tested intervention. The registered 296 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 2 interventions - of which insulin aspart is the first listed.
NCT00537303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00537303 about?
NCT00537303 is a clinical study titled "Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes". This trial is conducted in Europe, Africa and the United States of America (USA). The aim of this trial is to compare the safety and efficacy of two different insulin treatments, the "basic" and the "advanced" treatment in type 2 diabetes.
What is the current status of trial NCT00537303?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 296 participants. The study started on 2007-10. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00537303?
The interventions under investigation include: insulin aspart (DRUG), insulin detemir (DRUG).
Who is sponsoring clinical trial NCT00537303?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00537303's enrollment target sits among peer trials
296 294th of 2000 higher than 1,707 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05563792 · 296 participants · NA
Options for Pain Management Using Nonpharmacological Strategies
- NCT06828445 · 296 participants · Phase 1
Increasing Affordable Fruits and Vegetables for Families With Food Insecurity
- NCT06920563 · 296 participants · NA
Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education
- NCT06309160 · 297 participants · NA
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia